Dimethyl fumarate attenuates 2-VO-induced vascular dementia via activating the Nrf2 signaling pathway in rats
Authors (first, second and last of 4)

Experimental and Therapeutic Studies
Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing pain therapy. This includes comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. Topics include Conditional Pharmacology/Toxicology, Rheumatology, Gastroenterology, Neuro-Inflammation and Novel Drugs, Natural Products and Nutraceuticals. Types of inflammatory conditions include gastrointestinal disease (e.g. upper GI ulceration and bleeding, ulcerative colitis, Crohn's disease), various arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle
Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS).
The journal has seven main interest areas:
Requirements for manuscripts on the pharmacological or inflammatory properties of natural products are described in the editorial Inflammopharmacology Vol. 15, issue 5 or on the journal website: www.springer.com/10787
Details Concerning the Submission and Publication Procedures:
- No Page Charges
- No Fees for Online Color Images
- Optional Color Images in Print – EUR 950/USD 1150. VAT or local taxes will be added where applicable.
- Optional Open Access Publication Fee (APC) - EUR 2990/USD 3760/GBP 2490. VAT or local taxes will be added where applicable.